Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Works by van Nes, Falco
Results: 4
1
2
No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2020, v. 43, n. 10, p. e118, doi. 10.2337/dc20-1246
- By:
- Publication type:
- Article
3
Liraglutide for Weight Management in the Real World: Significant Weight Loss Even if the Maximal Daily Dose Is Not Achieved.
- Published in:
- Obesity Facts: The European Journal of Obesity, 2022, v. 15, n. 1, p. 83, doi. 10.1159/000520217
- By:
- Publication type:
- Article
4
Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT.
- Published in:
- Diabetologia, 2021, v. 64, n. 12, p. 2725, doi. 10.1007/s00125-021-05589-y
- By:
- Publication type:
- Article